From: Differential expression of anterior gradient gene AGR2 in prostate cancer
 | All Patients (n = 187) | Stage III/IV Patients (n = 65) | ||||
---|---|---|---|---|---|---|
Variable | HR | 95% CI | P-Value | HR | 95% CI | P-Value |
AGR2 continuous | 0.89 | 0.57 - 1.38 | 0.596 | 0.50 | 0.24 - 1.04 | 0.062 |
AGR2 dichotomized | 0.75 | 0.44 - 1.27 | 0.281 | 0.37 | 0.17 - 0.81 | 0.013 |
Gleason sum1 | 3.78 | 2.26 - 6.33 | < 0.0001 | 1.88 | 0.90 - 3.93 | 0.093 |
Preoperative PSA | 1.02 | 1.00 - 1.03 | 0.011 | 1.00 | 0.98 - 1.02 | 0.884 |
pT stage2 | 3.89 | 2.36 - 6.40 | < 0.0001 | 2.63 | 1.26 - 5.49 | 0.010 |